Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 10 Colorectal Neoplasms 8 Stomach Neoplasms 6 Pancreatic Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Breast Neoplasms 5 Keratosis, Actinic 4 Nasopharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Pseudomyxoma Peritonei 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Locally Advanced Rectal Cancer 1 Keratosis 1 Hyperthermia 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Appendiceal Neoplasms 1 Anus Neoplasms 1 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1 Advanced Colorectal Cancer 1

Interventions

Diathermy 9 Radiotherapy 6 Solutions 2 Hydrogen Peroxide 2 Cisplatin 2 Brachytherapy 2 Temozolomide 1 Saline Solution 1 Radiation 1 Laser Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Folfox protocol 1 Fluorouracil 1 Electrosurgery 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Cryotherapy 1 Control Groups 1 Consolidation Chemotherapy 1 Conization 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hyperthermia × Fluorouracil × Clear all

NCT06831981 2025-02-18

ARO 2024-13

University Hospital Tuebingen

Phase NA Recruiting

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡